In a tumultuous day for Wall Street, a widespread sell-off sent shockwaves through the financial landscape as U.S. stocks faced the brunt of a dangerous surge in Treasury yields.
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy and the broader industry trend to shed low-growth segments.